Correction: Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios
Lingli Zhang, Chu‐Chung Huang, Yuan Dai, Qiang Luo, Yiting Ji, Kai Wang, Shining Deng, Juehua Yu, Mingyu Xu, Xiujuan Du, Yun Tang, Chun Shen, Jianfeng Feng, Barbara J. Sahakian, Ching‐Po Lin, Fēi Li
Abstract
An important detail was omitted in the Method of the original Article, I.E, The CARS and other evaluations were conducted 'blind' to condition (Bumetanide or no treatment) by experienced clinicians. This has now been updated in the HTML and PDF versions of this Article.
Topics & Concepts
BumetanideAutism spectrum disorderAutismGlutamate receptorPsychiatryPsychologyMedicineAudiologyClinical psychologyInternal medicineChemistryCotransporterSodiumOrganic chemistryReceptorAutism Spectrum Disorder ResearchGenetics and Neurodevelopmental DisordersAttention Deficit Hyperactivity Disorder